Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767

Karilyn Gower, Press Officer
w. (202) 588-7779

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog

Follow us on Twitter


March 19, 2013

Good Move, But Years Late: FDA Warns Maker of ‘Fat-Burning’ Device to Stop Marketing Unapproved Product

Statement of Dr. Michael Carome, Deputy Director of Public Citizen’s Health Research Group

Note: Note: On July 18, 2012, Public Citizen sent a letter to the U.S. Food and Drug Administration, urging the agency to act immediately to end the distribution, sale and promotion of the LipoTron medical device because it had not been approved for the use for which it was being promoted and it could harm patients. Earlier this month, the FDA sent the manufacturer a letter, telling it that the device needs FDA approval and should not be marketed until that approval has been given.

The Food and Drug Administration (FDA) is doing the right thing by warning RevecoMED International, the maker of the LipoTron “fat-burning” device, to stop marketing the device, which has not been FDA-approved for “fat-burning.”

However, the action comes years too late. The illegal distribution and promotion of the LipoTron device was first brought to the FDA’s attention in January 2010. It should not have taken the agency so long to respond. While the FDA dragged its feet, patients were in harm’s way and likely wasted money on an unproven treatment. The agency is supposed to protect the public, not allow it to be exposed to potentially harmful and ineffective products.

The LipoTron device has been promoted for use in removing subcutaneous and visceral fat, and has been sold as the major component of a weight loss program called Lipo-Ex. However, it poses a risk of burns, and sufficient data have not been submitted to the FDA documenting that the device is effective for its intended uses.

The FDA’s March 1 letter to the company admonishes it to take prompt actions to correct the violations and bring the device into compliance with the law.

We urge the agency to ensure the company responds and to follow up with prompt aggressive enforcement action if it doesn’t.


Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.